NeoDocs is a Mumbai health-tech company that turns a smartphone into a diagnostic reader. Users dip a paper test card in a urine sample, scan it with the NeoDocs app, and get lab-referenced results in under a minute - covering kidney, metabolic and general wellness markers. Founded by three IIT Bombay alumni and backed by Y Combinator (S21) and Omidyar Network India, it sells test kits direct to consumers and works with thousands of doctors across India.
Numen (formerly Cleancard) is a San Francisco biotech building rapid at-home cancer screens that read like a pregnancy test. By combining synthetic biology, machine learning, and computer vision, its platform detects multiple cancer biomarkers from a single urine sample in about 30 minutes, with no lab machinery required. Founded by Rhodes Scholars Thomas Carroll and Luca Springer, the company's first screens target prostate, bladder, and ovarian cancer, with a mission to drive cancer mortality toward zero.
Mira is a women's health company that built the first at-home hormone monitor with lab-grade accuracy. Its connected device, single-use wands and AI-powered app measure FSH, LH, estrogen (E3G) and PdG so users can map fertility windows, manage PCOS, navigate menopause and share clinical-grade data with their doctors.